Know Cancer

or
forgot password

Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma


N/A
N/A
N/A
Open (Enrolling)
Both
Uveal Melanoma

Thank you

Trial Information

Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma


Inclusion Criteria:



- diagnosis of uveal melanoma

Exclusion Criteria:

- refusal to participate in the study

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Significant increase in biomarker level that could be linked with detection of metastases by imaging

Outcome Description:

Serum will be taken on every clinic visit from the day of diagnosis and on. Change in biomarker level will be assessed from one visit to the previous one, and correlated with imaging information on detection of metastases.

Outcome Time Frame:

up to 12 months before diagnosis of metastases

Safety Issue:

No

Principal Investigator

Shahar Frenkel, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Hadassah Medical Organization

Authority:

Israel: Ministry of Health

Study ID:

001-HMO-CTIL

NCT ID:

NCT01438658

Start Date:

September 2011

Completion Date:

December 2040

Related Keywords:

  • Uveal Melanoma
  • uveal melanoma
  • metastatic uveal melanoma
  • Melanoma
  • Uveal Neoplasms

Name

Location